Skip to content

Evaluation of Efficacy of AI Assistant System in Breast Cancer Screening

Evaluation of Efficacy of AI Assistant System in Breast Cancer Screening

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0009008
Enrollment
14000
Registered
2023-11-30
Start date
2023-02-02
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

National Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Applicants who underwent breast cancer screening at the National Cancer Center Screening Center between January 1, 2019 and December 31, 2019 and January 1, 2021 and December 31, 2021 2. Age and gender: Female aged 40-75 (recommended age group for national cancer screening)

Exclusion criteria

Exclusion criteria: 1. Under 40 years old, over 75 years old 2. If mammography is not performed due to a contraindication to mammography (Chest trauma, pregnancy, lactation, etc.) 3. When normal mammography images are not interpreted for the following reasons: - Previous breast cancer surgery - Breast implants (implants, clips, markers, etc.) - Insertion of pacemaker - Other inappropriate mammography images, etc.

Design outcomes

Primary

MeasureTime frame
Recall rate (comparison of change in recall rate before and after introduction of artificial intelligence reading support system)

Secondary

MeasureTime frame
Comparison of recall rate changes within and between readers before and after introducing an artificial intelligence reading support system;Comparison of differences in recall rates according to examinee factors (age, density, BMI, etc.)

Countries

Korea, Republic of

Contacts

Public ContactJo MI Seon

National Cancer Center

73454@ncc.re.kr+82-31-920-2358

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026